Epirubicin and thyroid cancer Patient Reports February 12, 2012

Epirubicin Side Effects Report #6037806-1
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Jan 02, 2009. Male patient, child 7 years of age, was diagnosed with rhabdomyosarcoma, diagnostic procedure and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: thyroid cancer . Epirubicin dosage: 840 MG, 9 CYCLES,. During the same period patient was treated with ETOPOSIDE, IFOSFAMIDE, DACTINOMYCIN, THERAPEUTIC RADIOPHARMACEUTICALS, VINCRISTINE, CARBOPLATIN. Patient recovered.

Epirubicin Side Effects Report #6049499-8
Epirubicin side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 05, 2009. Male patient, child 7 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: lymphadenopathy, thyroid cancer . Epirubicin dosage: 840 MG;. During the same period patient was treated with ETOPOSIDE, DACTINOMYCIN, CARBOPLATIN, IFOSFAMIDE, VINCRISTINE. Patient recovered.

Epirubicin Side Effects Report #6054970-9
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Dec 31, 2008. Male patient, child 7 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: thyroid cancer . Epirubicin dosage: unknown. During the same period patient was treated with DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, CARBOPLATIN, VINCRISTINE SULPHATE. Patient recovered.

Epirubicin Side Effects Report #6065683-1
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Jan 15, 2009. Male patient, child 7 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: metastases to lymph nodes, radiation exposure, thyroid cancer . Epirubicin dosage: unknown. During the same period patient was treated with DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, CARBOPLATIN, VINCRISTINE SULPHATE. Patient recovered.


Epirubicin Side Effects Report #6120093-3
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Feb 11, 2009. Male patient, child 7 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: thyroid cancer . Epirubicin dosage: unknown. During the same period patient was treated with DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, CARBOPLATIN, VINCRISTINE SULPHATE. Patient recovered.

Epirubicin Side Effects Report #6134248-5
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Mar 10, 2009. Male patient, child 7 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: thyroid cancer . Epirubicin dosage: unknown. During the same period patient was treated with DACTINOMYCIN, ETOPOSIDE, IFOSFAMIDE, CARBOPLATIN, VINCRISTINE SULPHATE. Patient recovered.

Epirubicin Side Effects Report #6070731-9
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Jan 28, 2009. Female patient was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: neoplasm malignant, thyroid cancer . Epirubicin dosage: 840 MG. During the same period patient was treated with ETOPOSIDE, DACTINOMYCIN, IFOSFAMIDE, CARBOPLATIN, VINCRISTINE SULPHATE. Patient recovered.

Epirubicin Side Effects Report #6046708-6
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Jan 16, 2009. Male patient, child 7 years of age, was diagnosed with rhabdomyosarcoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: neoplasm malignant, thyroid cancer . Epirubicin dosage: 840 MG, UNK. During the same period patient was treated with ETOPOSIDE, DACTINOMYCIN, IFOSFAMIDE, CARBOPLATIN, VINCRISTINE SULPHATE. Patient recovered.